在日益增长的响应要求中,老鼠对自行服用口服甲基胺的动机较低
Justin R Yates1, Kevin L Berling2, Maria R Broderick2
1Department of Psychological Science, Northern Kentucky University, 1 Nunn Drive, Highland Heights, KY 41099, USA.
Behavioural brain research
|September 17, 2023
概括
随着所需的努力增加,老鼠对自行服用口服甲基胺 (METH) 的动机降低了. 在甲基胺使用障碍研究中的这一发现表明,小鼠的口服METH自给量很低,类似于小鼠.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学 是一个学科.
- 行为科学 行为科学
背景情况:
- 甲基胺 (METH) 的使用和过量服用死亡人数显著增加.
- 了解甲基胺使用障碍 (MUD) 机制对于有效治疗至关重要.
- 在动物模型中,口服METH自给药的研究不足.
研究的目的:
- 为了调查老鼠是否表现出口服METH的动机下降,随着响应要求的不断升级.
- 为了比较大鼠口服METH自给与以前观察到的小鼠行为.
主要方法:
- 训练了16只斯普拉格·道利 (Sprague Dawley) 老鼠,让它们自行服用口服METH溶液.
- 使用固定比率 (FR) 时间表,从FR 1增加到FR 10.
- 对越来越多的FR要求进行响应输出测量.
主要成果:
- 在FR 10表中,大鼠对口服METH的反应显著下降.
- 这表明随着响应要求的升级,动机减少了.
结论:
- 老鼠表现出自我服用口服甲基胺的动机较低.
- 这些发现与先前对小鼠的研究一致,表明跨物种的行为反应得到保护.
更多相关视频
相关概念视频
Adrenergic Agonists: Mixed-Action Agents
775
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
775
Drug Abuse and Addiction: Pharmacological Phenomena
507
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
507
Phase II Reactions: Methylation Reactions
226
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
226
Drug Dependence
1.0K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.0K
Drugs Acting on Autonomic Ganglia: Stimulants
1.4K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.4K
Adrenergic Agonists: Indirect-Acting Agents
1.7K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.7K


